STAT6 Transcription Factor
"STAT6 Transcription Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-4. Stat6 has been shown to partner with NF-KAPPA B and CCAAT-ENHANCER-BINDING PROTEINS to regulate GENETIC TRANSCRIPTION of interleukin-4 responsive GENES.
Descriptor ID |
D050800
|
MeSH Number(s) |
D12.644.360.024.342.600 D12.776.157.057.186.600 D12.776.476.024.430.600 D12.776.930.840.600
|
Concept/Terms |
STAT6 Transcription Factor- STAT6 Transcription Factor
- Transcription Factor, STAT6
- STAT6 Protein
- Signal Transducer and Activator of Transcription 6
|
Below are MeSH descriptors whose meaning is more general than "STAT6 Transcription Factor".
Below are MeSH descriptors whose meaning is more specific than "STAT6 Transcription Factor".
This graph shows the total number of publications written about "STAT6 Transcription Factor" by people in this website by year, and whether "STAT6 Transcription Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2017 | 4 | 7 | 11 |
2018 | 1 | 7 | 8 |
2019 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "STAT6 Transcription Factor" by people in Profiles.
-
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells. J Cell Mol Med. 2019 12; 23(12):8010-8018.
-
Spatial distribution of IL4 controls iNKT cell-DC crosstalk in tumors. Cell Mol Immunol. 2020 05; 17(5):496-506.
-
LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization. Cancer Immunol Res. 2019 02; 7(2):292-305.
-
Cytokine-Based Generation of CD49a+Eomes-/+ Natural Killer Cell Subsets. Front Immunol. 2018; 9:2126.
-
Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis. Mol Pharm. 2018 08 06; 15(8):3456-3467.
-
LPS Exposure in Early Life Protects Against Mucus Hypersecretion in Ovalbumin-Induced Asthma by Down-Regulation of the IL-13 and JAK-STAT6 Pathways. Cell Physiol Biochem. 2018; 46(3):1263-1274.
-
Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features. Ann Diagn Pathol. 2018 Jun; 34:142-150.
-
Induction of IL-10-balanced immune profiles following exposure to LTA from Staphylococcus epidermidis. Exp Dermatol. 2018 04; 27(4):318-326.
-
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma. Blood. 2018 05 31; 131(22):2413-2425.
-
Mechanism of Periostin Production in Human Bronchial Smooth Muscle Cells. Int Arch Allergy Immunol. 2018; 175(1-2):26-35.